SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Amyotrophic Lateral Sclerosis (ALS)

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-als
Related Entities
diseases-als
Metadata
slugdiseases-als
entity_typedisease
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (407)
mentions🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy70%
mentions🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧪Circadian-Synchronized Proteostasis Enhancement65%
mentions🧪Arginine Methylation Enhancement Therapy65%
mentions🧪The Glial Ketone Metabolic Shunt Hypothesis65%
mentions🧪PARP1 Inhibition Therapy65%
mentions🧪Glycine-Rich Domain Competitive Inhibition65%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In65%
mentions🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy65%
mentions🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration65%
mentions🧪R-Loop Resolution Enhancement Therapy65%
mentions🧪Transglutaminase-2 Cross-Linking Inhibition Strategy65%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation65%
mentions🧪Vocal Cord Neuroplasticity Stimulation65%
mentions🧪Nucleolar Stress Response Normalization65%
mentions🧪Cross-Seeding Prevention Strategy65%
mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection65%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming65%
mentions🧪RNA Granule Nucleation Site Modulation65%
related🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy63%
related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub63%
mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme60%
mentions🧪Cryptic Exon Silencing Restoration60%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples60%
mentions🧫TDP-43 mutant mouse model cGAS/STING pathway analysis60%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples60%
mentions🧫TDP-43 mitochondrial invasion and DNA release via mPTP60%
mentions🧫cGAS/STING pathway validation in TDP-43 mutant mice60%
mentions🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto60%
mentions🧫cGAS/STING pathway activation by TDP-43-released mtDNA60%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%
mentions🔬What are the mechanisms underlying rna binding protein dysre60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬RNA binding protein dysregulation across ALS FTD AD60%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes60%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD60%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
mentions🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
mentions🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Brainstem Circuit Modulation for PSP60%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
related🧫Progranulin Replacement Therapy for FTD — Vector Development60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
related🧪Circadian-Synchronized Proteostasis Enhancement58%
related🧪Arginine Methylation Enhancement Therapy58%
related🧪The Glial Ketone Metabolic Shunt Hypothesis58%
related🧪PARP1 Inhibition Therapy58%
related🧪Glycine-Rich Domain Competitive Inhibition58%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In58%
related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy58%
related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration58%
related🧪R-Loop Resolution Enhancement Therapy58%
related🧪Transglutaminase-2 Cross-Linking Inhibition Strategy58%
related🧪Serine/Arginine-Rich Protein Kinase Modulation58%
related🧪Vocal Cord Neuroplasticity Stimulation58%
related🧪Nucleolar Stress Response Normalization58%
related🧪Cross-Seeding Prevention Strategy58%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection58%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming58%
related🧪RNA Granule Nucleation Site Modulation58%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors55%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy55%
mentions🧫Metabolic Pathway-Targeted Therapy in ALS55%
mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker55%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri55%
mentions🧫Brainstem Circuit Modulation for PSP55%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT55%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio55%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design55%
mentions🧫N-of-1 Clinical Trial Design for CBS/PSP55%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic55%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development55%
mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD55%
mentions🧫PSP and CBS Biomarker Validation Study55%
mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des55%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme54%
related🧪Cryptic Exon Silencing Restoration54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples54%
related🧫TDP-43 mutant mouse model cGAS/STING pathway analysis54%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples54%
related🧫TDP-43 mitochondrial invasion and DNA release via mPTP54%
related🧫cGAS/STING pathway validation in TDP-43 mutant mice54%
related🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto54%
related🧫cGAS/STING pathway activation by TDP-43-released mtDNA54%
related🔬What are the mechanisms underlying tdp-43 phase separation t54%
related🔬What are the mechanisms underlying rna binding protein dysre54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🔬Analyze the spectrum of microglial activation states (DAM, h54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🔬RNA binding protein dysregulation across ALS FTD AD54%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes54%
related🔬RNA binding protein dysregulation across ALS FTD and AD54%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
mentions🧫CD2AP expression and cognitive decline in AD patients50%
mentions🧫CD2AP downregulation in brain endothelial cells - memory fun50%
mentions🧫Cerebrovascular function analysis in CD2AP mutant mice50%
mentions🧫Mouse Cdk5, p35, and p39 mutations in neuronal migration50%
mentions🧫Reelin pathway defects in human type 2 lissencephaly50%
mentions🧫s:** - Test whether HCN1 knockout specifically in EC layer I50%
mentions🧫tACS Connectivity Trial in Early Alzheimer's50%
mentions🧫MAP6 depletion effects on neuronal development in primary cu50%
mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 50%
mentions🧫Prion Strain Diversity and Selective Vulnerability50%
mentions🧫Microtubule domain analysis in adult axons50%
mentions🧫Tau depletion effects on neuronal development in primary cul50%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%
mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro50%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
related🧪APOE Isoform Conversion Therapy50%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
related🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
related🧪Competitive APOE4 Domain Stabilization Peptides50%
related🧪APOE Isoform Expression Across Glial Subtypes50%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
related🧪SASP-Driven Aquaporin-4 Dysregulation50%
related🧪Aquaporin-4 Polarization Rescue50%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
related🧪Lysosomal Membrane Repair Enhancement50%
related🧪Extracellular Vesicle Biogenesis Modulation50%
related🧪Temporal Decoupling via Circadian Clock Reset50%
related🧪Circadian Clock-Autophagy Synchronization50%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
related🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor50%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
related🧪Liquid-Liquid Phase Separation Modifier Therapy50%
related🧪Stress Granule Phase Separation Modulators50%
related🧪Phase-Separated Organelle Targeting50%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
related🧪The Glial Ketone Metabolic Shunt Hypothesis50%
related🧪Lysosomal Enzyme Trafficking Correction50%
related🧪Lysosomal Positioning Dynamics Modulation50%
related🧪Lysosomal Calcium Channel Modulation Therapy50%
related🧪Mitochondrial Transfer Pathway Enhancement50%
related🧪APOE-Dependent Autophagy Restoration50%
related🧪Microglial Purinergic Reprogramming50%
related🧪Purinergic P2Y12 Inverse Agonist Therapy50%
related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption50%
related🧪Perforant Path Presynaptic Terminal Protection Strategy50%
related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy50%
related🧪Autophagosome Maturation Checkpoint Control50%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
related🧪Epigenetic Memory Erasure via TET2 Activation50%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
related🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction50%
related🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling50%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
related🧪APOE-TREM2 Interaction Modulation50%
related🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
related🧪TREM2-Dependent Microglial Senescence Transition50%
related🧪TREM2-mediated microglial tau clearance enhancement50%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
related🧪VCP-Mediated Autophagy Enhancement50%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
related🧪SASP-Mediated Complement Cascade Amplification50%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
related🧪CYP46A1 Overexpression Gene Therapy50%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
related🧪Axonal RNA Transport Reconstitution50%
related🧪Mitochondrial-Lysosomal Contact Site Engineering50%
related🧪Synaptic Vesicle Tau Capture Inhibition50%
related🧪APOE-Mediated Synaptic Lipid Raft Stabilization50%
related🧪Transcriptional Autophagy-Lysosome Coupling50%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
related🧪Targeted Butyrate Supplementation for Microglial Phenotype M50%
related🧪Extracellular Matrix Stiffness Modulation50%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
related🧪Mitochondrial RNA Granule Rescue Pathway50%
related🧪Low Complexity Domain Cross-Linking Inhibition50%
related🧪Transglutaminase-2 Cross-Linking Inhibition Strategy50%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🧪Mitochondrial SPM Synthesis Platform Engineering50%
related🧪CX43 hemichannel engineering enables size-selective mitochon50%
related🧪Senescent Cell Mitochondrial DNA Release50%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
related🧪Heat Shock Protein 70 Disaggregase Amplification50%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement50%
see_also🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
see_also🧪APOE Isoform Conversion Therapy50%
see_also🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
see_also🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
see_also🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
see_also🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
see_also🧪Competitive APOE4 Domain Stabilization Peptides50%
see_also🧪APOE Isoform Expression Across Glial Subtypes50%
see_also🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
see_also🧪SASP-Driven Aquaporin-4 Dysregulation50%
see_also🧪Aquaporin-4 Polarization Rescue50%
see_also🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
see_also🧪Lysosomal Membrane Repair Enhancement50%
see_also🧪Extracellular Vesicle Biogenesis Modulation50%
see_also🧪Temporal Decoupling via Circadian Clock Reset50%
see_also🧪Circadian Clock-Autophagy Synchronization50%
see_also🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
see_also🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor50%
see_also🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
see_also🧪Liquid-Liquid Phase Separation Modifier Therapy50%
see_also🧪Stress Granule Phase Separation Modulators50%
see_also🧪Phase-Separated Organelle Targeting50%
see_also🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
see_also🧪The Glial Ketone Metabolic Shunt Hypothesis50%
see_also🧪Lysosomal Enzyme Trafficking Correction50%
see_also🧪Lysosomal Positioning Dynamics Modulation50%
see_also🧪Lysosomal Calcium Channel Modulation Therapy50%
see_also🧪Mitochondrial Transfer Pathway Enhancement50%
see_also🧪APOE-Dependent Autophagy Restoration50%
see_also🧪Microglial Purinergic Reprogramming50%
see_also🧪Purinergic P2Y12 Inverse Agonist Therapy50%
see_also🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption50%
see_also🧪Perforant Path Presynaptic Terminal Protection Strategy50%
see_also🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy50%
see_also🧪Autophagosome Maturation Checkpoint Control50%
see_also🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
see_also🧪Epigenetic Memory Erasure via TET2 Activation50%
see_also🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
see_also🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction50%
see_also🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling50%
see_also🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
see_also🧪APOE-TREM2 Interaction Modulation50%
see_also🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
see_also🧪TREM2-Dependent Microglial Senescence Transition50%
see_also🧪TREM2-mediated microglial tau clearance enhancement50%
see_also🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
see_also🧪VCP-Mediated Autophagy Enhancement50%
see_also🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
see_also🧪SASP-Mediated Complement Cascade Amplification50%
see_also🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
see_also🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
see_also🧪CYP46A1 Overexpression Gene Therapy50%
see_also🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
see_also🧪Axonal RNA Transport Reconstitution50%
see_also🧪Mitochondrial-Lysosomal Contact Site Engineering50%
see_also🧪Synaptic Vesicle Tau Capture Inhibition50%
see_also🧪APOE-Mediated Synaptic Lipid Raft Stabilization50%
see_also🧪Transcriptional Autophagy-Lysosome Coupling50%
see_also🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
see_also🧪Targeted Butyrate Supplementation for Microglial Phenotype M50%
see_also🧪Extracellular Matrix Stiffness Modulation50%
see_also🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
see_also🧪Mitochondrial RNA Granule Rescue Pathway50%
see_also🧪Low Complexity Domain Cross-Linking Inhibition50%
see_also🧪Transglutaminase-2 Cross-Linking Inhibition Strategy50%
see_also🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
see_also🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%
see_also🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
see_also🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
see_also🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧫Experiment: Multi-Ethnic PD GWAS44%
mentions📖AAN 2026 — Amyotrophic Lateral Sclerosis40%
mentions📖AB Science40%
mentions📖ARCH Venture Partners40%
mentions📖Amgen40%
mentions📖Amylyx Pharmaceuticals, Inc.40%
mentions📖Arbor Biotechnologies40%
mentions📖Biohaven40%
mentions📖Blackrock Neurotech40%
mentions📖Blackrock Neurotech40%
mentions📖Boston University40%
mentions📖BrainCo40%
mentions📖CIEN Foundation40%
mentions📖Case Western Reserve University40%
mentions📖Charité – Universitätsmedizin Berlin40%
mentions📖Clene Nanomedicine40%
mentions📖Clene Nanomedicine, Inc.40%
mentions📖Cognixion40%
mentions📖Companies Dashboard40%
mentions📖Cryopraxis40%
mentions📖Cytokinetics, Inc.40%
mentions📖Forest Neurotech40%
mentions📖Fudan University40%
mentions📖GeNeuro40%
mentions📖Harvard Medical School40%
mentions📖Helios Inc.40%
mentions📖INSERM40%
mentions📖John Ravits40%
mentions📖Johnson & Johnson40%
mentions📖KU Leuven40%
mentions📖Kinevo Inc.40%
mentions📖Leonard Petrucelli40%
mentions📖MEDINFORM40%
mentions📖Massachusetts General Hospital40%
mentions📖Medical University of Vienna40%
mentions📖MindMaze40%
mentions📖Mitsubishi Tanabe Pharma Corporation40%
mentions📖Moscow State University40%
mentions📖Neuraly, Inc.40%
mentions📖NeuroWiki Progress40%
mentions📖NextMind40%
mentions📖Nippon Shinyaku Co., Ltd.40%
mentions📖Olink Proteomics40%
mentions📖OpenBCI Inc.40%
mentions📖Otsuka Holdings Co., Ltd.40%
mentions📖Paradromics40%
mentions📖Peking University40%
mentions📖Prionab40%
mentions📖QurAlis Corporation40%
mentions📖QurAlis40%
mentions📖RA Capital Management40%
mentions📖Regeneron Pharmaceuticals40%
mentions📖Regenxbio Inc.40%
mentions📖ReproCELL Inc.40%
mentions📖SanBio Co., Ltd.40%
mentions📖Servier40%
mentions📖Sorbonne University40%
mentions📖Teva Pharmaceutical Industries Ltd.40%
mentions📖Tsinghua University40%
mentions📖Universitat de Barcelona40%
mentions📖University of California, Berkeley40%
mentions📖University of Chicago40%
mentions📖University of Colorado Anschutz Medical Campus40%
mentions📖University of Edinburgh40%
mentions📖University of Illinois Urbana-Champaign40%
mentions📖University of Michigan40%
mentions📖University of North Carolina (UNC)40%
mentions📖University of North Carolina at Chapel Hill40%
mentions📖University of Oxford40%
mentions📖University of Rome Sapienza40%
mentions📖University of Rostock40%
mentions📖University of Tokyo40%
mentions📖Wave Life Sciences40%
mentions📖Wuxi Biologics40%
mentions📖Wyss Center40%
mentions📖can-fite-biopharma40%
mentions📖dzne40%
mentions📖feinstein-institutes-for-medical-research40%
mentions📖gladstone40%
mentions📖thomas-jefferson-university40%
mentions📖versant-ventures40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%
related🔬What are the mechanisms underlying selective vulnerability o36%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub